Target
Free fatty acid receptor 1
Ligand
BDBM300864
Substrate
n/a
Meas. Tech.
Calcium Flux Assay
EC50
10.00±n/a nM
Citation
 Huang, HKuo, GPlayer, MRYang, SZhang, Y Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes US Patent  US9790198 Publication Date 10/17/2017 
Target
Name:
Free fatty acid receptor 1
Synonyms:
FFAR1 | FFAR1_HUMAN | G-protein Coupled Receptor 40 | GPR40
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
31473.32
Organism:
Homo sapiens (Human)
Description:
O14842
Residue:
300
Sequence:
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK
  
Inhibitor
Name:
BDBM300864
Synonyms:
3-(6-((3-(4-(2,3- Dihydroxypropoxy)-2- phenyl)benzo[b]thiophen- 5-yl)methoxy)pyridin-3-yl) hex-4-ynoic acid | US10131648, Compound 62 | US10195178, Compound 62 | US9790198, Compound 62
Type:
Small organic molecule
Emp. Form.:
C30H29NO6S
Mol. Mass.:
531.619
SMILES:
CC#CC(CC(O)=O)c1ccc(OCc2ccc3scc(-c4ccc(OCC(O)CO)cc4C)c3c2)nc1
Structure:
Search PDB for entries with ligand similarity: